SCHEMBL24434872

SCHEMBL24434872

CC(C)C1(N(C)Cc2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.53
OPRL1 P41146 5/20 0.53
TSHR P16473 3/20 0.47
ALDH1A1 P00352 1/20 0.47
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
SLC6A2 P23975 1/20 0.46
HTR2A P28223 1/20 0.46
SLC6A4 P31645 1/20 0.46
ADRA1A P35348 1/20 0.46
OPRK1 P41145 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KCNH2 Q12809 1/20 0.46
AOC3 Q16853 1/20 0.44
HPGD P15428 1/20 0.40
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26986036 0.81 OPRM1 (0.49) OPRM1OPRL1TSHRALDH1A1ADRA2B
SCHEMBL26985915 0.75 L3MBTL1 (0.52) OPRM1OPRL1ALDH1A1OPRK1MEN1
SCHEMBL24434663 0.75 OPRM1 (0.58) OPRM1OPRL1TSHRALDH1A1ADRA2B
SCHEMBL3915316 0.74 OPRM1 (0.45) OPRM1OPRL1TSHRALDH1A1ADRA2B
SCHEMBL11348690 0.70 OPRM1 (0.53) OPRM1OPRL1TSHRALDH1A1ADRA2B
SCHEMBL9278699 0.70 OPRM1 (0.53) OPRM1OPRL1TSHRALDH1A1SLC6A2
SCHEMBL3409019 0.69 OPRL1 (1.00) OPRM1OPRL1OPRK1
SCHEMBL15111158 0.69 OPRM1 (0.51) OPRM1OPRL1TSHRALDH1A1AOC3
SCHEMBL10708855 0.69 OPRM1 (0.51) OPRM1OPRL1TSHRALDH1A1SLC6A2
SCHEMBL18756363 0.68 TSHR (0.54) OPRM1OPRL1TSHRALDH1A1ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G OPRM1 4412/4885OPRL1 3554/4885TSHR 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.